Regalia Pharmaceutical (India) Private Limited

Regalia Pharmaceutical (India) Private Limited - pharma in Pune, Maharashtra, India. FY 2026 financials & compliance.
CIN U24232PN2007PTC130885 Incorporated 20 October 2007 ROC Pune HQ Pune, Maharashtra, India
Active Private Limited Company pharma
Revenue · FY 2024
₹98.56 Lakh
▼ 15% YoY
Net loss · FY 2024
₹1.28 Lakh
Net margin -1.3%
EBITDA · FY 2024
₹2.72 Lakh
EBITDA margin 2.8%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹7.69 Lakh
Issued & subscribed
Open charges
₹20 Lakh
Secured borrowings
Company age
19 yrs
Est. 2007
Employees · EPFO
10
Provident fund records

About Regalia Pharmaceutical (India) Private Limited

Data last updated:

Regalia Pharmaceutical (India) Private Limited is a private limited company based in Pune, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 20 October 2007 and has been in existence for over 19 years.

The company is registered with the Registrar of Companies (ROC), Pune, under CIN U24232PN2007PTC130885. Its GSTIN is 27AADCR8274P1ZJ (Maharashtra).

The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹7.69 Lakh. It is led by directors Rohit Dinanath Karpe and Anil Popatrao Belkar.

Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Lower Ground Floor 112 Akruti Sankul S N 20112059 Sadashiv Peth, Pune, Maharashtra, India – 411030.

As per the financials filed for FY 2024, the company reported a revenue of ₹98.56 Lakh, a decline of 15% compared to the previous year. For the same year it recorded a net loss of ₹1.28 Lakh (net margin -1.3%) and EBITDA of ₹2.72 Lakh (EBITDA margin 2.8%). Revenue has declined at a compounded annual rate (CAGR) of 1% over three years and 32% over five years.

The company has about 10 employees on its provident fund (EPFO) records.

As per MCA filings, the company has open charges of ₹20 Lakh on record. Court records list 2 cases involving the company, including 2 filed against it.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website regaliapharma.com.

Company details

CIN U24232PN2007PTC130885
Registration Number 130885
Incorporation Date 20 October 2007
ROC Pune
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant

Contact details

Regalia Pharmaceutical (India) Private Limited's registered office is in Pune, Maharashtra. Its website is regaliapharma.com. Its e-mail address is in the company report.

  • Email
  • Registered Address
    Lower Ground Floor 112 Akruti Sankul S N 20112059 Sadashiv Peth, Pune, Maharashtra, India – 411030
  • Industry
    Pharma, Pharmaceutical Retailers & Distributors

To see the full contact details of Regalia Pharmaceutical (India) Private Limited, buy the company report.

Comprehensive company report
Regalia Pharmaceutical (India) Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Regalia Pharmaceutical (India) is trade. In detail, this covers retail trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG2Retail Trading

To see the full business activity and turnover split of Regalia Pharmaceutical (India) Private Limited, buy the company report.

Financials of Regalia Pharmaceutical (India) Private Limited

FY 2024 filings available

Regalia Pharmaceutical (India) Private Limited reported revenue of ₹98.56 Lakh (down 15% YoY) for FY 2024.

Revenue · FY 2024
₹98.56 Lakh ▼ 15%
Net loss · FY 2024
₹1.28 Lakh margin -1.3%
EBITDA · FY 2024
₹2.72 Lakh margin 2.8%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 15%
3 years · compounded
▲ 1%
5 years · compounded
▼ 32%
EBITDA CAGR growth
1 year
▼ 35%
3 years · compounded
▲ 27%
5 years · compounded
▲ 15%

Revenue has declined at a compounded annual rate (CAGR) of 32% over five years, including a 15% fall in the latest year. EBITDA fell 35% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹2.72 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹1.28 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profitability
EBITDA Margin2.8%
Net Profit Margin-1.3%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Regalia Pharmaceutical (India) Private Limited, buy the company report.

Board of directors of Regalia Pharmaceutical (India) Private Limited

Regalia Pharmaceutical (India) has 2 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Rohit Dinanath KarpeDirector20 Oct 200719 Years 0 MonthsCurrent
Anil Popatrao BelkarDirector31 Mar 20233 Years 7 MonthsCurrent

Auditor

Regalia Pharmaceutical (India) Private Limited is audited by ABHAY & RAHUL for the financial year 2022.

Auditor firmFinancial yearFirm registration number
ABHAY & RAHULFY 2022129965W

Shareholding

The shareholding of Regalia Pharmaceutical (India) Private Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, public shareholders and others.

Shareholder categoryFY 2022FY 2021FY 2020FY 2019FY 2018
Promoters
Domestic institutional investors (DII)
Public
Others

To see the full shareholding pattern of Regalia Pharmaceutical (India) Private Limited, buy the company report.

Charges & borrowings

Open charges
₹20 Lakh
Satisfied charges
None
Breakdown by lending institutions
Indian Bank₹0.20 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
08 Jul 2016100038767Indian Bank₹20 LakhOpen

Total charge records: 1 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Regalia Pharmaceutical (India) Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Regalia Pharmaceutical (India) has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
27AADCR8274P1ZJMaharashtraActive01 Jul 2017

To see the full GST registrations and return filing status of Regalia Pharmaceutical (India) Private Limited, buy the company report.

Recent activity

Regalia Pharmaceutical (India) Private Limited has 14 board changes on record since 2007: 8 appointments and 6 cessations. The latest: Anil Popatrao Belkar was appointed as Director on 31 Mar 2023.

AGM
Regalia Pharmaceutical (India) Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Regalia Pharmaceutical (India) Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Pune.
Appointed
Anil Popatrao Belkar was appointed as Director.
Ceased
Hitesh Popatlal Oswal ceased to be Director.
Ceased
Satish Shankarrao Gadewar ceased to be Director.
Ceased
Sheetal Prakash Bhandari ceased to be Director.
Ceased
Sameer Bhaskar Godbole ceased to be Director.
Appointed
Hitesh Popatlal Oswal was appointed as Director.
Charges
A charge with Indian Bank amounted to Rs. 20.00 Lakh with Charge ID 100038767 was registered on 08 Jul 2016.
Appointed
Satish Shankarrao Gadewar was appointed as Director.
Ceased
Dnyaneshwar Nivrutee Narhare ceased to be Director.
Appointed
Sameer Bhaskar Godbole was appointed as Director.

6 earlier events are in the company report.

Frequently asked questions

Regalia Pharmaceutical (India) is an active private limited company based in Pune, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 20 October 2007 (19+ years old) and is registered under CIN U24232PN2007PTC130885.

Regalia Pharmaceutical (India) has 2 current directors:

The latest financial statements of Regalia Pharmaceutical (India) on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.

The GSTIN of Regalia Pharmaceutical (India) is 27AADCR8274P1ZJ, registered in Maharashtra.

The CIN (Corporate Identification Number) of Regalia Pharmaceutical (India) is U24232PN2007PTC130885. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Regalia Pharmaceutical (India) has 2 court cases on record: 2 filed against it. Most are in the district courts.

Regalia Pharmaceutical (India) was incorporated on 20 October 2007, making it 19+ years old. It is registered with the Registrar of Companies, Pune.

Anil Popatrao Belkar was appointed as Director on 31 Mar 2023. Hitesh Popatlal Oswal ceased to be Director on 31 Mar 2023. Satish Shankarrao Gadewar ceased to be Director on 31 Mar 2023. Regalia Pharmaceutical (India) has 14 board changes on record in total.

Regalia Pharmaceutical (India) can be reached through the website regaliapharma.com. Its registered office is in Pune, Maharashtra, India.

The registered office of Regalia Pharmaceutical (India) is at Lower Ground Floor 112 Akruti Sankul S N 20112059 Sadashiv Peth, Pune, Maharashtra, India – 411030.